Which hormone best prevents endometrioma return after surgery?

NCT ID NCT07519213

First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study looked at over 1,100 women who had surgery for ovarian endometriomas (cysts caused by endometriosis) and then took one of four hormonal treatments to prevent recurrence. The goal was to see which treatment—birth control pills, GnRH agonists, dienogest, or dydrogesterone—was most effective at stopping new cysts from forming within two years. Results could help doctors choose the best post-surgery hormone therapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
hormonal treatments (combined oral contraceptives, GnRH agonists, dienogest, or dydrogesterone)
What this could lead to
If this study shows one hormonal regimen works better, it could help doctors choose the best option to prevent endometriomas from coming back after surgery.
What could go wrong
This is a retrospective study, not a controlled trial, so results may be influenced by unmeasured factors. The findings need confirmation in prospective studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Guangdong Women and Children Hospital

    Guangzhou, Guangdong, 511400, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.